LAVA Therapeutics's market cap is currently $24.58M. The company's EPS TTM is $-1.03; its P/E ratio is ―; LAVA Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 6.77M	$ 19.39M	$ 5.35M	$ 3.75M	$ 0.00
Gross Profit	$ 3.29M	$ 19.39M	$ 5.35M	$ -11.95M	$ -8.35M
Operating Income	$ -43.25M	$ -34.84M	$ -43.61M	$ -14.67M	$ -9.58M
EBITDA	$ -40.42M	$ -30.88M	$ -41.02M	$ -14.65M	$ -9.48M
Net Income	$ -41.97M	$ -31.91M	$ -42.35M	$ -15.93M	$ -9.69M
Balance Sheet
Cash & Short-Term Investments	$ 95.57M	$ 132.87M	$ 151.01M	$ 19.43M	$ 8.33M
Total Assets	$ 101.71M	$ 143.43M	$ 157.87M	$ 25.16M	$ 9.98M
Total Debt	$ 6.31M	$ 5.45M	$ 5.52M	$ 5.01M	$ 2.00M
Net Debt	$ -37.92M	$ -94.88M	$ -145.50M	$ -14.42M	-
Total Liabilities	$ 50.53M	$ 57.38M	$ 23.67M	$ 15.80M	$ 3.35M
Stockholders' Equity	$ 51.18M	$ 86.04M	$ 134.19M	$ 9.36M	$ 6.63M
Cash Flow
Free Cash Flow	$ -39.70M	$ 3.46M	$ -33.34M	$ -13.42M	$ -10.64M
Operating Cash Flow	$ -38.97M	$ 4.04M	$ -32.48M	$ -12.77M	-
Investing Cash Flow	$ -17.64M	$ 9.35M	$ -49.37M	-	-
Financing Cash Flow	$ -571.00K	$ 283.00K	$ 171.37M	$ 24.20M	$ 1.33M

Currency in USD

LAVA Therapeutics Earnings and Revenue History

Income Statement >

LAVA Therapeutics Debt to Assets

Balance Sheet >

LAVA Therapeutics Cash Flow

Cash Flow >

LAVA Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing